, Tracking Stock Market Picks
Enter Symbol:
Cephalon, Inc. (CEPH) [hlAlert]

Strong Buy
up 41.86 %

Cephalon, Inc. (CEPH) rated Strong Buy by Broadpoint Capital

Posted on: Wednesday,  Feb 13, 2008  8:25 AM ET by Broadpoint Capital

Broadpoint Capital rated Strong Buy Cephalon, Inc. (NASDAQ: CEPH) on 02/13/2008, when the stock price was $57.44.
Since then, Cephalon, Inc. has gained 41.87% as of 10/13/2011's recent price of $81.49.
If you would have followed this Broadpoint Capital's recommendation on CEPH, you would have gained 41.86% of your investment in 1338 days.

Cephalon is an international biopharmaceutical company focused on thediscovery, development and marketing of products to treat sleep disorders,neurological disorders, cancer and pain. In addition to an active research and development program, they market products in the United States and various countries in Europe.

Broadpoint Capital, Inc. is an investment banking and capital markets firm that provides corporate and public finance services and trading of corporate, government, and municipal securities for institutions. The company has three divisions: Municipal Capital Markets division, which underwrites and trades municipal securities in new issue and secondary markets; Taxable Fixed Income division, which is a dealer focusing on fixed income securities with limited liquidity; and Equity Capital Markets division, which is a sector-focused investment banking group providing research, trading, raising of capital and advisory services for institutional and corporate clients. Broadpoint Capital, formerly known as First Albany Corporation, was founded in 1953 and is based in New York, New York. The company operates as a subsidiary of First Albany Companies Inc.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/13/2008 8:25 AM Buy
as of 12/24/2008
1 Week down  -2.67 %
1 Month down  -0.51 %
3 Months down  -15.10 %
1 YTD down  -14.92 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy